Background Several immune‐mediated diseases have been shown to be associated with
an increased risk of cardiovascular disease. However, studies evaluating the association …

Inflammatory bowel disease (IBD) refers to a group of chronic inflammatory diseases that
targets mainly the gastrointestinal tract. The clinical presentation of IBD includes both …

Background & Aims Tofacitinib is an oral, small-molecule Janus kinase inhibitor for the
treatment of ulcerative colitis (UC). We analyzed inflammation, lipid concentrations, and …

During their metabolism, all lipoproteins undergo endocytosis, either to be degraded
intracellularly, for example in hepatocytes or macrophages, or to be re-secreted, for example …

Inflammatory bowel diseases (IBDs) are chronic immunological disorders of the intestinal
tract characterized by persistent inflammation. Baicalin, a type of flavonoid, has exhibited a …

The last decade has seen epidemiological evidence of a positive association between high
consumption of red meat and processed meat and the risk of develo** a range of chronic …

Inflammatory bowel disease (IBD), classified primarily between Crohn's disease and
ulcerative colitis, is a collection of chronic gastrointestinal inflammatory conditions that cause …

Background Inflammatory bowel disease (IBD) patients present a higher risk of develo**
cardiovascular diseases due to the presence of chronic inflammation, which plays an …

Patients with inflammatory bowel disease (IBD) have an increased risk of develo**
venous thromboembolic events, which have a considerable impact on morbidity and …

Cardiovascular disease (CVD) can arise because of chronic inflammation and inflammatory
bowel disease (IBD) is one such disease where the risk for CVD and eventual heart failure is …